IMMvention Therapeutix
Dr. Junkins has 15+ years of research experience in the fields of innate immunology, cell biology, and biochemistry. He completed his BSc (Hons) In Biochemistry and Molecular Biology and his Ph.D. in Microbiology and Immunology at Dalhousie University in Nova Scotia, Canada. He went on to receive postdoctoral training in Immunology and Genetics at UNC-Chapel Hill in the lab of Dr. Jenny Ting where he developed deep expertise and a keen interest in the inflammasome field, and where he was a key driver in the inception of IMMvention Therapeutix. Dr. Junkins has widely published in high-profile scientific journals spanning multiple disciplines and is an inventor on multiple patents.
Outside of the lab, Rob can be found training for his next marathon, tackling endless DIY projects, or spending some quality time with his family.
This person is not in any offices
IMMvention Therapeutix
IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that is at the root cause of some of the following diseases.